# Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

> **NCT00402805** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 50 (estimated)

## Conditions studied

- Lung Transplantation
- Influenza Vaccines

## Interventions

- **BIOLOGICAL:** Trivalent Inactivated Influenza Vaccine

## Key facts

- **NCT ID:** NCT00402805
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-02
- **Final completion:** 2007-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402805, "Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00402805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*